Buzzi, Marie
Ricci, Laetitia
Gibot, Sébastien
Argaud, Laurent
Badie, Julio
Bruel, Cédric
Charpentier, Claire
Outin, Hervé
Louis, Guillaume
Monnier, Alexandra
Quenot, Jean-Pierre
Schneider, Francis
Minary, Laetitia
Agrinier, Nelly
Article History
Received: 1 January 2024
Accepted: 17 July 2024
First Online: 24 July 2024
Declarations
:
: All health professionals gave oral consent to participate in the qualitative approach. The Comité de Protection des Personnes Est III, Grand-Est, North-East France, has reviewed and approved POINCARE-2 trial (ID-RCB: 2015-A00662-47). Patients and their kin were informed about the trial protocol and their right to refuse to participate. Written informed consent was waived in accordance with the French law (Bill number 2012 − 300 on March 5, 2012 about research involving humans).
: Not applicable.
: The authors declare no competing interests.